参考文献/References:
[1]Wen PY,Huse JT.2016 World Health Organization Classification of Central Nervous System Tumors[J].Continuum (Minneap Minn),2017,23(6):1531-1547.[2]Youssef G,Miller JJ.Lower Grade Gliomas[J].Curr Neurol Neurosci Rep,2020,20(7):21. [3]Burak Atci I,Yilmaz H,Samanci MY.The top 50 most-cited articles on low-grade glioma: a bibliometric analysis[J].Br J Neurosurg,2019,33(2):171-175.[4]Budia I,Alvarez-Arenas A,Woolley TE,et al.Radiation protraction schedules for low-grade gliomas: a comparison between different mathematical models[J].J R Soc Interface,2019,16(161):20190665.[5]Garcia CR,Slone SA,Pittman T,et al.Comprehensive evaluation of treatment and outcomes of low-grade diffuse gliomas[J].PLoS One,2018,13(9):e0203639.[6]Jin YP,Valenzuela NM,Zhang X,et al.HLA Class II-Triggered Signaling Cascades Cause Endothelial Cell Proliferation and Migration: Relevance to Antibody-Mediated Transplant Rejection[J].J Immunol,2018,200(7):2372-2390.[7]Ramia E,Chiaravalli AM,Bou Nasser Eddine F,et al.CIITA-related block of HLA class II expression, upregulation of HLA class I, and heterogeneous expression of immune checkpoints in hepatocarcinomas: implications for new therapeutic approaches[J].Oncoimmunology,2018,8(3):1548243.[8]Cioni B,Jordanova ES,Hooijberg E,et al.HLA class II expression on tumor cells and low numbers of tumor-associated macrophages predict clinical outcome in oropharyngeal cancer[J].Head Neck,2019,41(2):463-478.[9]Garrido F.HLA Class-II Expression in Human Tumors[J].Adv Exp Med Biol,2019(1151):91-95.[10]郭传军.HLA-DMA rs1063478位点多态性与胶质瘤易感性及mTOR通路与高级别胶质瘤预后的关系[D].济南:山东大学,2016.[11]Wang Q,He Z,Chen Y.Comprehensive Analysis Reveals a 4-Gene Signature in Predicting Response to Temozolomide in Low-Grade Glioma Patients[J].Cancer Control,2019,26(1):1073274819855118.[12]Wang S,Jin F,Fan W,et al.Gene expression meta-analysis in diffuse low-grade glioma and the corresponding histological subtypes[J].Sci Rep,2017,7(1):11741.[13]Jakola AS,Skjulsvik AJ,Myrmel KS,et al.Surgical resection versus watchful waiting in low-grade gliomas[J].Ann Oncol,2017,28(8):1942-1948.[14]Xu B.Prediction and analysis of hub genes between glioblastoma and low-grade glioma using bioinformatics analysis[J].Medicine,2021,100(3):e23513.[15]Xu X,Lai Y,Hua ZC.Apoptosis and apoptotic body: disease message and therapeutic target potentials[J].Biosci Rep,2019,39(1):BSR20180992.[16]Villanova L,Careccia S,De Maria R,et al.Micro-Economics of Apoptosis in Cancer: ncRNAs Modulation of BCL-2 Family Members[J].Int J Mol Sci,2018,19(4):958.[17]Carneiro BA,El-Deiry WS.Targeting apoptosis in cancer therapy[J].Nat Rev Clin Oncol,2020,17(7):395-417.[18]Pfeffer CM,Singh ATK.Apoptosis: A Target for Anticancer Therapy[J].Int J Mol Sci,2018,19(2):448. [19]Cao LJ,Xie HT,Chu ZX,et al.Tubeimoside-1 induces apoptosis in human glioma U251 cells by suppressing PI3K/Akt-mediated signaling pathways[J].Mol Med Rep,2020,22(2):1527-1535.[20]Liu Y,Yaozu Z,Zhao H,et al.Inhibition of Glioma Cell Growth and Apoptosis Induction through Targeting Wnt10B Expression by Pyrazolo[4,3-c]pyridine-4-one[J].Med Sci Monit,2020(26):e923912.